Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lohberger, B; Steinecker-Frohnwieser, B; Stuendl, N; Kaltenegger, H; Leithner, A; Rinner, B.
The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy.
PLoS One. 2016; 11(12):e0168193-e0168193
Doi: 10.1371/journal.pone.0168193
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Lohberger Birgit
- Co-Autor*innen der Med Uni Graz
- Kaltenegger Heike
- Leithner Andreas
- Rinner Beate
- Steinecker-Frohnwieser Bibiane
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- High grade chondrosarcoma is characterized by its lack of response to conventional cytotoxic chemotherapy, the tendency to develop lung metastases, and low survival rates. Research within the field prioritizes the development and expansion of new treatment options for dealing with unresectable or metastatic diseases. Numerous clinical trials using the proteasome inhibitor bortezomib have shown specific efficacy as an active antitumor agent for treating a variety of solid tumors. However, as of yet the effect of bortezomib on chondrosarcoma has not been investigated. In our study, bortezomib decreased cell viability and proliferation in two different chondrosarcoma cell lines in a time- and dose dependent manner. FACS analysis, mRNA- and protein expression studies illustrated that induction of apoptosis developed through the intrinsic mitochondria-caspase dependent pathway. Furthermore, bortezomib treatment significantly increased expression of the death receptors TRAILR-1 and TRAILR-2 in chondrosarcoma cells. An increased expression of the autophagy markers Atg5/12, Beclin, and LC3BI-II supports the interpretation that bortezomib functions as a trigger for autophagy. Our results demonstrated for the first time that bortezomib reduced viability and proliferation of chondrosarcoma cells, induced apoptosis via the mitochondria-caspase dependent pathway and enhanced death receptor expression and autophagy.
- Find related publications in this database (using NLM MeSH Indexing)
- Autophagy - drug effects
- Autophagy-Related Protein 5 - metabolism
- Beclin-1 - metabolism
- Biomarkers - metabolism
- Bone Neoplasms - metabolism
- Bortezomib - pharmacology
- Caspases - metabolism
- Cell Line, Tumor -
- Chondrosarcoma - metabolism
- Humans -
- Mitochondria - metabolism
- Proteasome Inhibitors - pharmacology
- Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism
- Signal Transduction - drug effects